TP53 and neoplasm: GLS2 overexpression elicits an antiproliferative response involving mitochondria and cell nucleus; the nuclear targeting correlated with a p53-dependent tumor suppressive mechanism allowing proliferation arrest of human cancer cells at G2/M.